The Changing Landscape of Autoimmune Hemolytic Anemia
Autoimmune hemolytic anemia (AIHA) is a greatly heterogeneous disease due to autoantibodies directed against erythrocytes, with or without complement activation. The clinical picture ranges from mild/compensated to life-threatening anemia, depending on the antibody's thermal amplitude, isotype...
Main Authors: | Wilma Barcellini, Bruno Fattizzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00946/full |
Similar Items
-
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1
by: Wilma Barcellini, et al.
Published: (2020-11-01) -
Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
by: Bruno Fattizzo, et al.
Published: (2020-11-01) -
Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
by: Bruno Fattizzo, et al.
Published: (2020-06-01) -
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
by: Irina Murakhovskaya
Published: (2020-12-01) -
Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
by: Wilma Barcellini, et al.
Published: (2021-01-01)